Before the United States! What is the safety and efficacy of the world's first weekly injection of insulin approved in China? The century old development of insulin has finally ushered in a new breakthrough! On June 24, the State Drug Administration (NMPA) officially approved the launch of the world's first weekly insulin preparation, insulin enoxaparin injection ("Novo phase"), developed by Novo Nordisk, in China for the treatment of adult type 2 diabetes. This breakthrough also ushered in the era of insulin therapy weekly preparations.